<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13084">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01654107</url>
  </required_header>
  <id_info>
    <org_study_id>R34DA030652</org_study_id>
    <nct_id>NCT01654107</nct_id>
  </id_info>
  <brief_title>Persistence-Targeted Smoking Cessation</brief_title>
  <acronym>PTSC</acronym>
  <official_title>Persistence-Targeted Smoking Cessation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <authority>United States: Data and Safety Monitoring Board</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to develop a theory-based smoking cessation intervention (called
      Persistence-targeted smoking cessation; PTSC).  PTSC includes 8 weekly individual counseling
      sessions and use of nicotine lozenge for 12 weeks.  The investigators will test the
      feasibility and preliminary efficacy of the intervention (i.e., cigarettes per day and
      prolonged abstinence).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this Stage I Behavioral &amp; Integrative Treatment Development (R34) project, we propose to
      develop a theory-based smoking cessation intervention (called Persistence-targeted smoking
      cessation; PTSC).  PTSC includes 8 weekly individual counseling sessions and use of nicotine
      lozenge for 12 weeks.  We will test the feasibility and preliminary efficacy of the
      intervention (i.e., cigarettes per day and prolonged abstinence).  We hope to develop a
      feasible psychosocial treatment for use in a later randomized controlled trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Prolonged abstinence</measure>
    <time_frame>3-months</time_frame>
    <safety_issue>No</safety_issue>
    <description>3-months after the Quit Date</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>Persistence Targeted Smoking Cessation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Persistence Targeted Smoking Cessation - 8 weeks counseling + 12 weeks nicotine lozenge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clearing The Air</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clearing the Air Smoking Cessation intervention - 8 weeks counseling + 12 weeks nicotine lozenge</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Persistence Targeted Smoking Cessation</intervention_name>
    <description>8-weeks of smoking cessation counseling (&quot;Persistence Targeted Smoking Cessation&quot;)</description>
    <arm_group_label>Persistence Targeted Smoking Cessation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Clearing The Air</intervention_name>
    <description>8-weeks counseling + 12-weeks nicotine lozenge based on NCI protocol, Clearing The Air</description>
    <arm_group_label>Clearing The Air</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine lozenge</intervention_name>
    <description>12-weeks 4mg nicotine lozenge</description>
    <arm_group_label>Persistence Targeted Smoking Cessation</arm_group_label>
    <arm_group_label>Clearing The Air</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be between 18 - 64 years old

          -  Must smoke at least 10 cigarettes per day for past 6-months

          -  Expired breath carbon monoxide (CO) &gt; 7

          -  Must have a working cellular phone

        Exclusion Criteria:

          -  Must not be currently receiving tobacco dependence treatment counseling

          -  Must not currently be taking varenicline, bupropion, or any nicotine preparations
             (gum, lozenge, patch, spray, inhaler)

          -  Must have no contraindications to using nicotine lozenge
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc L Steinberg, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers, The State University of New Jersey</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc L Steinberg, Ph.D.</last_name>
    <phone>(732) 235-3904</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Rutgers Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc L Steinberg, Ph.D.</last_name>
      <phone>732-235-3904</phone>
    </contact>
    <investigator>
      <last_name>Marc L Steinberg, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 13, 2014</lastchanged_date>
  <firstreceived_date>July 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tobacco</keyword>
  <keyword>smoking cessation</keyword>
  <keyword>nicotine dependence</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Smoking</mesh_term>
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Nicotine polacrilex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
